By PPN News Staff
The FDA granted accelerated approval to pemigatinib (Pemazyre, Incyte Corporation), the first treatment approved for adults with certain types of previously treated, advanced cholangiocarcinoma.
APRIL 20, 2020
APRIL 20, 2020
By PPN News Staff
The FDA granted accelerated approval to pemigatinib (Pemazyre, Incyte Corporation), the first treatment approved for adults with certain types of previously treated, advanced cholangiocarcinoma.